DEMAPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DEMAPHARMA
Largest movements
- Tangible fixed assets -€29,809
down €29,809 (-14.6%), from €204,236 to €174,427
- Debts after one year -€69,530
down €69,530 (-28.0%), from €248,034 to €178,504
of which Financial debts: -€60,841
- Reserves +€17,290
up €17,290 (+4.9%), from €349,446 to €366,736
- Other debts +€14,471
new in 2025: €14,471
- Trade debts +€7,179
up €7,179 (+341.9%), from €2,100 to €9,279
- Gross operating margin -€6,131
down €6,131 (-4.8%), from €128,911 to €122,780
- Financial charges -€3,944
down €3,944 (-20.8%), from €18,988 to €15,044
- Taxes +€2,178
up €2,178 (+29.1%), from €7,485 to €9,663
- Staff costs +€1,805
up €1,805 (+3.9%), from €45,739 to €47,544
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €689,799 | €659,253 | -€30,546 | -4.4% |
| Fixed assets | 21/28 | €661,507 | €631,698 | -€29,809 | -4.5% |
| Tangible fixed assets | 22/27 | €204,236 | €174,427 | -€29,809 | -14.6% |
| Land and buildings | 22 | €122,023 | €107,905 | -€14,118 | -11.6% |
| Furniture and vehicles | 24 | €3,837 | €2,860 | -€977 | -25.5% |
| Other tangible fixed assets | 26 | €78,376 | €63,663 | -€14,714 | -18.8% |
| Financial fixed assets | 28 | €457,270 | €457,270 | = | 0.0% |
| Current assets | 29/58 | €28,292 | €27,556 | -€737 | -2.6% |
| Amounts receivable within one year | 40/41 | €11,057 | €4,582 | -€6,475 | -58.6% |
| Trade receivables | 40 | €0 | €1 | +€1 | |
| Other amounts receivable | 41 | €11,057 | €4,581 | -€6,476 | -58.6% |
| Current investments | 50/53 | €11,000 | €11,387 | +€387 | +3.5% |
| Cash at bank and in hand | 54/58 | €3,739 | €8,543 | +€4,804 | +128.5% |
| Deferred charges and accrued income | 490/1 | €2,497 | €3,044 | +€547 | +21.9% |
| Total equity and liabilities | 10/49 | €689,799 | €659,253 | -€30,546 | -4.4% |
| Equity | 10/15 | €368,046 | €385,336 | +€17,290 | +4.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €349,446 | €366,736 | +€17,290 | +4.9% |
| Distributable reserves | 133 | €349,446 | €366,736 | +€17,290 | +4.9% |
| Amounts payable | 17/49 | €321,753 | €273,917 | -€47,836 | -14.9% |
| Amounts payable after more than one year | 17 | €248,034 | €178,504 | -€69,530 | -28.0% |
| Financial debts | 170/4 | €229,575 | €168,735 | -€60,841 | -26.5% |
| Other amounts payable | 178/9 | €18,458 | €9,769 | -€8,689 | -47.1% |
| Amounts payable within one year | 42/48 | €73,720 | €95,398 | +€21,678 | +29.4% |
| Current portion of amounts payable after more than one year | 42 | €58,562 | €60,841 | +€2,279 | +3.9% |
| Financial debts | 43 | €2,329 | €2,345 | +€16 | +0.7% |
| Credit institutions | 430/8 | €2,329 | €2,345 | +€16 | +0.7% |
| Trade debts | 44 | €2,100 | €9,279 | +€7,179 | +341.9% |
| Suppliers | 440/4 | €2,100 | €9,279 | +€7,179 | +341.9% |
| Taxes, remuneration and social security | 45 | €10,728 | €8,461 | -€2,267 | -21.1% |
| Taxes | 450/3 | €2,403 | €1,507 | -€896 | -37.3% |
| Remuneration and social security | 454/9 | €8,325 | €6,954 | -€1,371 | -16.5% |
| Other amounts payable | 47/48 | - | €14,471 | +€14,471 | |
| Accrued charges and deferred income | 492/3 | - | €16 | +€16 | |
| Non-recurring operating income | 76A | €0 | €0 | +€0 | |
| Remuneration, social security and pensions | 62 | €45,739 | €47,544 | +€1,805 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €29,480 | €29,809 | +€328 | +1.1% |
| Other operating charges | 640/8 | €2,874 | €3,130 | +€256 | +8.9% |
| Non-recurring operating charges | 66A | €281 | €387 | +€106 | +37.7% |
| Gross operating margin | 9900 | €128,911 | €122,780 | -€6,131 | -4.8% |
| Operating profit (loss) | 9901 | €50,537 | €41,910 | -€8,627 | -17.1% |
| Financial income | 75/76B | - | €88 | +€88 | |
| Recurring financial income | 75 | - | €88 | +€88 | |
| Financial charges | 65/66B | €18,988 | €15,044 | -€3,944 | -20.8% |
| Recurring financial charges | 65 | €18,988 | €15,044 | -€3,944 | -20.8% |
| Profit (loss) for the period before taxes | 9903 | €31,548 | €26,953 | -€4,595 | -14.6% |
| Income taxes | 67/77 | €7,485 | €9,663 | +€2,178 | +29.1% |
| Profit (loss) for the period | 9904 | €24,063 | €17,290 | -€6,773 | -28.1% |
| Profit (loss) for the period to be appropriated | 9905 | €24,063 | €17,290 | -€6,773 | -28.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.